Carolyn Johnson
When did our human ancestors arrive in Europe? 1.4-million-year-old artifacts made by hominids track their migration
An artifact-rich archaeological site in western Ukraine may be the oldest spot in Europe to contain evidence of early humans ...
‘We’ve got miraculous therapies for ‘bubble boy disease’ that don’t fit in anyone’s business model’: Mainstream care elusive for most patients because of high costs
Hataałii Tiisyatonii “HT” Begay was born with a form of severe combined immunodeficiency, or SCID, which meant he had virtually ...
Race for a cure: ‘After decades of neglect, stigma and underfunding, sickle cell is getting the red carpet treatment in science.’ Here’s what that means
The first gene therapies for sickle cell, including one based on the buzzy, Nobel Prize-winning technique called CRISPR ...
Blood dinner: Why are you targeted by mosquitoes but some lucky few are spared?
Researchers built the ‘world’s largest perfumery for mosquitoes’ to test why some people get eaten alive while others do not ...
‘A whole new class of drugs to fight malaria’: Single dose of antibody infusion protects for six months
A single dose of an antibody drug provided strong protection against malaria infections during the six-month rainy season in Mali, ...
Switch in strategy: Why the next COVID vaccine could be a nasal spray
The virus had gained a stunning ability to infect people, jumping from one person’s nose to the next. Cases soared ...
On the path to a universal COVID vaccine
Is chasing the latest variant a viable strategy? Instead of testing and potentially deploying a new shot when a new ...
When will we know for certain the health risks posed by the Omicron variant?
Over Thanksgiving, [microbiologist Pei-Yong Shi] began engineering a replica of the new variant to test against the antibodies generated by ...
Latest COVID variant Omicron proving ‘formidable, but not unstoppable’
A sobering portrait of the omicron variant is emerging from the first burst of laboratory studies on the coronavirus’s latest ...
Inside the quest to develop second-generation vaccines, variant-proof boosters and a shot that works against future pandemics
Even as vaccine supplies outstrip demand in the United States, the scientific quest for coronavirus shots has scarcely eased. In ...
Unwitting COVID carriers: 20-college study trying to answer when it will be safe to go maskless
All three authorized vaccines in the United States offer recipients robust protection against illness, particularly the worst cases. But how ...
Evolution and COVID-19: How nature is staying one step ahead of vaccines and the dangers that pose for the years ahead
As scientists work to get a handle on [COVID] variants, the situation gives the public a rare front-row seat and ...
Moderna tweaking COVID vaccine to target evasive new variants
[A] highly transmissible variant first detected in people who had recently traveled to Brazil was discovered in Minnesota. Moderna, the ...
Pfizer-BioNTech vaccine appears to protect against South African, UK COVID variants
[A new] study showed the immunity conferred by the Pfizer-BioNTech vaccine could block a version of the virus that contained one key ...
Easy-to-administer single shot COVID vaccine from Johnson & Johnson in final phase testing
[An] experimental vaccine being developed by pharmaceutical giant Johnson & Johnson is the fourth vaccine to enter the large, Phase 3 ...
Science checking Trump’s touted convalescent plasma COVID treatment
President Trump announced [August 23] that he had helped break through a regulatory “logjam” to grant emergency authorization of convalescent ...
No HIV vaccine yet but decades of false starts provide guidance to coronavirus researchers
Thirty-six years [after the virus's discovery], there still is no HIV vaccine. But instead of being a cautionary tale of ...
Wanted: Volunteers willing to risk getting sick from the coronavirus for the greater good
The Covid-19 Prevention Network, which knits together the existing federal clinical trial infrastructure developed largely to test HIV vaccines and ...
Big risk, big rewards: Betting on RNA to make cheaper, faster coronavirus vaccines
[A] promising — but unproven — new generation of vaccine technologies is based on deploying a tiny snip of genetic ...
Even with a vaccine, COVID-19 might be here to stay. Here’s what that means for society
It is a daunting proposition — a coronavirus-tinged world without a foreseeable end. But experts in epidemiology, disaster planning and ...
Quest for coronavirus vaccine is the new ‘space race’. Will bragging rights go to China or the US?
The same day in mid-March that the United States launched human testing of its first experimental coronavirus vaccine, scientists in ...
Older vaccines for polio and tuberculosis could ‘rev up’ the body’s immune system to counter COVID-19
Two tried-and-true vaccines — a century-old inoculation against tuberculosis and a decades-old polio vaccine once given as a sugar cube ...
Moderna announces July clinical trials after experimental coronavirus vaccine shows promising early results
Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results from its ...
‘It’s a cacophony’: Quest for coronavirus treatments undermined by ‘disorganized and scattershot’ US approach
In a desperate bid to find treatments for people sickened by the coronavirus, doctors and drug companies have launched more ...
Bringing ‘medical lore’ to life: Century-old practice of plasma infusions could be used against coronavirus
An old idea for fighting infections — an approach most physicians know about only from medical lore — is being ...
3 scientists win Nobel Prize in medicine for work on cell’s ability to ‘sense and adapt to oxygen availability’
The Nobel Prize in physiology or medicine was awarded Monday to three physician-scientists from the U.S. and Britain — William ...
Second person cured of HIV? Stem cell transplant sends ‘London patient’ into long-term remission
A man has been in remission from HIV for a year and a half, without drugs, after receiving a stem ...
Esketamine nasal spray, touted as biggest advance in years for treating depression, gets FDA approval
The Food and Drug Administration approved a novel antidepressant late Tuesday [March 5] for people with depression that does not ...